BRAFTOVI (encorafenib) capsules
BRAFTOVI can be used in combination with binimetinib (called MEKTOVI) to treat adult patients who have a type of skin cancer called melanoma, which has spread to other parts of the body, or cannot be removed by surgery, and which has a particular change. FDA approved encorafenib (brand name BRAFTOVI) is not (yet) registered or available in India but on request Indian patient can buy BRAFTOVI at the lowest price. (mutation) in the gene that produces a protein called BRAF.
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
BRAFTOVI (encorafenib) capsules
Encorafenib is used along with binimetinib (Mektovi) to treat certain types of melanoma (a type of skin cancer) that has spread to other parts of the body or cannot be removed by surgery.
BRAFTOVI is a kinase inhibitor indicated, in combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.
Encorafenib, is a medication for the treatment of certain melanoma cancers. It is a small molecule BRAF inhibitor that targets key enzymes in the MAPK signaling pathway. In June 2018, it was approved by the FDA in combination with binimetinib for the treatment of patients with unresectable or metastatic BRAF V600E or V600K mutation-positive melanoma. In October 2023, the US Food and Drug Administration approved encorafenib with binimetinib for adults with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by an FDA-approved test.
Drug (Brand / Generic): BRAFTOVI / encorafenib
Current Indication: treat melanoma
Approval Date: Aug 1, 2019
Array BioPharma
Capsules: 50 mg and 75 mg.
BRAFTOVI (encorafenib) is supplied as 50 mg and 75 mg hard gelatin capsules. Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see
USP Controlled Room Temperature]. Do not use if safety seal under cap is broken or missing. Dispense in
original bottle. Do not remove desiccant. Protect from moisture. Keep container tightly closed.
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ BRAFTOVI (encorafenib) capsules ”. FDA approved encorafenib (brand name BRAFTOVI) is not (yet) registered or available in India but on request Indian patient can buy BRAFTOVI at the lowest price. Confirmation of the order for BRAFTOVI (encorafenib) capsules will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to FDA approved encorafenib (brand name BRAFTOVI) India.
For personal use, get access to FDA approved encorafenib (brand name BRAFTOVI) India. On request, We have imported and delivered Anti-cancer medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
BRAFTOVI Sourcing & Delivery
Alleviare India specializes in sourcing and supplying BRAFTOVI, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of BRAFTOVI in India.
How much does BRAFTOVI cost in the India?
Kindly reach out to us for BRAFTOVI (encorafenib) capsules price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import BRAFTOVI to India?
To import encorafenib BRAFTOVI, patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:
Valid prescription from a qualified doctor.
Patients’ diagnostic reports.
Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
Valid prescription from the doctor.
Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is BRAFTOVI available in India?
BRAFTOVI encorafenib is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of BRAFTOVI (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Please contact or mail @ – info@alleviareindia.com +91 9289711087 / 9289711088 for BRAFTOVI availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is encorafenib available in India?
Yes, FDA approved encorafenib (brand name BRAFTOVI) is not (yet) registered or available in India but on request Indian patient can buy BRAFTOVI at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand BRAFTOVI (encorafenib) capsules . The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to BRAFTOVI (encorafenib) capsules , they can inquire and find further information by sending their inquiries to ALS.
